ABVC vs CLOV
ABVC Biopharma Inc (ABVC) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ABVC currently screens at market cap $35.9M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ABVC and CLOV stock pages for the full models.
Not investment advice.